AKT1 and non-small cell lung carcinoma: Additionally, atorvastatin suppressed the activation of ERK and AKT and disrupted Kras/PI3K and Kras/Raf complex formation in the NSCLC cells through its inhibitory action on HMG-CoA reductase [38].